172 related articles for article (PubMed ID: 30338052)
1. Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber S; Lang R; Steiner M; Aglas L; Ferreira F; Wallner M; Hawranek T; Gadermaier G
Clin Transl Allergy; 2018; 8():39. PubMed ID: 30338052
[TBL] [Abstract][Full Text] [Related]
2. The role of IgG
Strobl MR; Demir H; Sánchez Acosta G; Drescher A; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2023 May; 151(5):1371-1378.e5. PubMed ID: 36657603
[TBL] [Abstract][Full Text] [Related]
3.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
4. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
5. IgE and allergen-specific immunotherapy-induced IgG
Groh N; von Loetzen CS; Subbarayal B; Möbs C; Vogel L; Hoffmann A; Fötisch K; Koutsouridou A; Randow S; Völker E; Seutter von Loetzen A; Rösch P; Vieths S; Pfützner W; Bohle B; Schiller D
Clin Exp Allergy; 2017 May; 47(5):693-703. PubMed ID: 27770477
[TBL] [Abstract][Full Text] [Related]
6. Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1.
Svenson M; Jacobi HH; Bødtger U; Poulsen LK; Rieneck K; Bendtzen K
Mol Immunol; 2003 Jan; 39(10):603-12. PubMed ID: 12431394
[TBL] [Abstract][Full Text] [Related]
7. IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice.
Ganglberger E; Grünberger K; Wiedermann U; Vermes M; Sponer B; Breiteneder H; Scheiner O; Boltz G; Jensen-Jarolim E
Int Arch Allergy Immunol; 2001; 124(1-3):395-7. PubMed ID: 11307026
[TBL] [Abstract][Full Text] [Related]
8. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
[TBL] [Abstract][Full Text] [Related]
9. Establishment of enzyme-linked immunosorbent facilitated antigen binding as a biomarker assay for Japanese cedar pollen allergy immunotherapy.
Fukano C; Ohashi-Doi K; Lund K; Nakao A; Masuyama K; Matsuoka T
J Pharmacol Sci; 2019 Jul; 140(3):223-227. PubMed ID: 31353210
[TBL] [Abstract][Full Text] [Related]
10. Heterogenous Induction of Blocking Antibodies against Ragweed Allergen Molecules by Allergen Extract-Based Immunotherapy Vaccines.
Zbîrcea LE; Buzan MR; Grijincu M; Cotarcă MD; Tamaș TP; Haidar L; Tănasie G; Huțu I; Babaev E; Stolz F; Valenta R; Păunescu V; Panaitescu C; Chen KW
Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932364
[TBL] [Abstract][Full Text] [Related]
11. Expression of a human IgG4 antibody, BAB2, with specificity for the major Birch pollen allergen, Bet v 1 in Escherichia coli: recombinant BAB2 Fabs enhance the allergic reaction.
Eibensteiner P; Denépoux S; Steinberger P; Kraft D; Visco V; Banchereau J; Lebecque S; Valenta R
Int Arch Allergy Immunol; 1999; 118(2-4):190-2. PubMed ID: 10224374
[TBL] [Abstract][Full Text] [Related]
12. A sensitive assay for the detection of IgE bound to the major birch pollen allergen, Bet v 1, in the form of immune complexes.
Pree I; Reisinger J; Bohle B; Frantal S; Valenta R; Niederberger V
J Immunol Methods; 2009 Jun; 345(1-2):100-5. PubMed ID: 19376122
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological characterization and standardization of allergens.
Kaul S; Scheurer S; Danz N; Schicktanz S; Vieths S; Hoffmann A
J Allergy Clin Immunol; 2003 Jun; 111(6):1262-8. PubMed ID: 12789227
[TBL] [Abstract][Full Text] [Related]
14. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
15. Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1.
Mirza O; Henriksen A; Ipsen H; Larsen JN; Wissenbach M; Spangfort MD; Gajhede M
J Immunol; 2000 Jul; 165(1):331-8. PubMed ID: 10861069
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
[TBL] [Abstract][Full Text] [Related]
17. Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.
Akinfenwa O; Huang HJ; Linhart B; Focke-Tejkl M; Vrtala S; Poroshina A; Nikonova A; Khaitov M; Campion NJ; Eckl-Dorna J; Niederberger-Leppin V; Kratzer B; Tauber PA; Pickl WF; Kundi M; Campana R; Valenta R
Front Immunol; 2021; 12():744544. PubMed ID: 34795666
[TBL] [Abstract][Full Text] [Related]
18. Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy.
Mikus M; Zandian A; Sjöberg R; Hamsten C; Forsström B; Andersson M; Greiff L; Uhlén M; Levin M; Nilsson P; van Hage M; Ohlin M
J Allergy Clin Immunol; 2021 Mar; 147(3):1077-1086. PubMed ID: 32791163
[TBL] [Abstract][Full Text] [Related]
19. Peptide epitopes as biomarkers of soya sensitization in rBet v 1 immunotherapy of birch-related soya allergy.
Caballero LR; Treudler R; Delaroque N; Simon JC; Kern K; Szardenings M
Clin Exp Allergy; 2023 Mar; 53(3):316-326. PubMed ID: 36102274
[TBL] [Abstract][Full Text] [Related]
20. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
